Abstract
We shortly discuss a possible contribution of insulin-degrading enzyme to Alzheimer´s disease pathology by binding varicella zoster virus glycoprotein E, which increases the infectivity and cell–cell spread of the virus.
References
Koelsch G (2017) BACE1 function and Inhibition: implications of intervention in the amyloid pathway of Alzheimer’s Disease pathology. Molecules 22. https://doi.org/10.3390/molecules22101723
Bernstein HG, Ansorge S, Riederer P, Reiser M, Frölich L, Bogerts B (1999) Insulin-degrading enzyme in the Alzheimer’s disease brain: prominent localization in neurons and senile plaques. Neurosci Lett 263:161–164
Kurochkin IV, Guarnera E, Berezovsky IN (2018) Insulin-degrading enzyme in the fight against Alzheimer’s disease. Trends Pharmacol Sci 39:49–58. https://doi.org/10.1016/j.tips.2017.10.008
Pivovarova O, Höhn A, Grune T, Pfeiffer AF, Rudovich N (2016) Insulin-degrading enzyme: new therapeutic target for diabetes and Alzheimer’s disease? Ann Med 48:614–624
Itzhaki RF (2018) Corroboration of a major role for Herpes Simplex Virus Type 1 in Alzheimer’s disease. Front Aging Neurosci 10:324. https://doi.org/10.3389/fnagi.2018.00324
Hemling N, Röyttä M, Rinne J, Pöllänen P, Broberg E, Tapio V, Vahlberg T, Hukkanen V (2003) Herpesviruses in brains in Alzheimer’s and Parkinson’s diseases. Ann Neurol 54:267–271
Tsai M-C, Cheng W-L, Sheu J-J, Huang C-C, Shia B-C, Kao LT, Lin HC (2017) Increased risk of dementia following herpes zoster ophthalmicus. PLoS One 12(11):e0188490. https://doi.org/10.1371/journal.pone.0188490(eCollection 2017)
Chen V, Wu C-H, Huang C-H, Yang SI, Kuo K-Y, Liang Y-H, Huang T-Y, Gossop KL M (2018) Herpes zoster and dementia. J Clin Psychiatry 79:16 m11312. https://doi.org/10.4088/JCP.16m11312
Ukraintseva S, Akushevich I, Yashkin A, Krachenko JV, Arbeev K, Kulminsky A, Polity R, Tropsha A, Yashin AI (2017) On the role of infection in Alzheimer´s disease (AD): Herpes viruses areassociated with significant increase in AD risk in a large population—representative sample of eldery individuals. Alzheimer’s Dement 13(Suppl.):1423–1424
Li Q, Ali MA, Cohen JI (2006) Insulin degrading enzyme is a cellular receptor mediating varicella-zoster virus infection and cell-to-cell spread. Cell 127(2):305–316
Li Q, Ali MA, Wang K, Sayre D, Hamel FG, Fischer ER, Bennett RG, Cohen JI (2010) Insulin degrading enzyme induces a conformational change in Varicella-Zoster Virus gE, and enhances virus infectivity and stability. PLoS One 5(6):e11327. https://doi.org/10.1371/journal.pone.001132
De Tullio MB, Laura Morelli L, Castaño EM (2008) The irreversible binding of amyloid peptide substrates to insulin-degrading enzyme A biological perspective. Prion 2:51–56
Funding
There was no funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors have no conflict of interest to report.
Rights and permissions
About this article
Cite this article
Bernstein, HG., Keilhoff, G., Dobrowolny, H. et al. Binding varicella zoster virus: an underestimated facet of insulin-degrading enzyme´s implication for Alzheimer´s disease pathology?. Eur Arch Psychiatry Clin Neurosci 270, 495–496 (2020). https://doi.org/10.1007/s00406-019-00995-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00406-019-00995-1